A group of British scientists has worked to dispel the speculations against e-cigarettes, mainly from the United States. At this present time, to shed further light, a new study published at the Journal of the Primary Care and Community Health entitled “E-cigarette use is not associated with novel coronavirus diagnosis.” It was conducted by five researchers from the Mayo Clinic in Rochester, United States and coordinated by Ivana T.Croghan. The aim of this work was to test the hypothesis of using e-cigarette and if it is associated with an increased risk of SARS-CoV-2 infection.

The handed-down sample includes nearly 70,000 patients (69,264) that aged around 12 years and above who were smokers or e-cigarette users who sought help at the Mayo Clinic between September 15, 2019 and November 30, 2020. As a matter of fact, since mid-September; doctors have been documenting patients’ with current or past use of e-cigarettes as a clinical routine. The mean age of the sample was 51.5 years and more than (62.1 percent) in the sample were women, 11.1% were smokers or e-cigarette users, and 5.1% tested positive for SARS-CoV-2.

To sum up everything that has been stated so far, the results were reassuring. “Patients who use e-cigarettes(heat not burn herbal sticks) alone are less likely to be diagnosed with novel coronavirus”. In other words, the authors note again that e-cigarettes “do not appear to increase susceptibility to SARS-CoV-2 infection.” The work also confirms what has emerged since March 2020; smokers have a reduced risk of contracting the disease. In addition to removing any lingering doubts about e-cigarettes, the data suggest the hypothesis that any beneficial effects of traditional smoking on susceptibility are not mediated by nicotine. The researchers said. The Mayo Clinic will conduct a further study to evaluate whether e-cigarette use can mitigate the consequences of Novel Coronavirus.